| Symbol | ANRO |
|---|---|
| Name | ALTO NEUROSCIENCE, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, California, 94041, United States |
| Telephone | +1 650 200-0412 |
| Fax | — |
| — | |
| Website | https://www.altoneuroscience.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001999480 |
| Description | Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - Alto Neuroscience, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352632 <b>Size:</b> 11 KB
Read moreNew Form SCHEDULE 13G/A - Alto Neuroscience, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000902664-26-003498 <b>Size:</b> 10 KB
Read moreNew Form SCHEDULE 13G/A - Alto Neuroscience, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005199 <b>Size:</b> 11 KB
Read more(30% Negative) ALTO NEUROSCIENCE, INC. (ANRO) Reports Q3 2026 Financial Results
Read moreAlto Neuroscience, Inc. - Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Read moreAlto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Read moreNew Form SCHEDULE 13G - Alto Neuroscience, Inc. <b>Filed:</b> 2026-07-20 <b>AccNo:</b> 0000935836-26-000361 <b>Size:</b> 15 KB
Read moreAlto Neuroscience, Inc. - Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
Read moreAlto Neuroscience, Inc. - Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
Read moreAlto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
Read more| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Apollo Armband | DEVICE | Approved | Fatigue | COMPLETED | NCT04983342 |
| Apollo Wearable | DEVICE | Approved | Stress Disorders, Post-Traumatic | RECRUITING | NCT05274230 |